Olanzapine, another atypical neuroleptic, has been reported to improve OCD symptoms when added to fluoxetine in one case report
7575
Pharmacologic intervention may be considered for treatment of PTSD if none of the indicated psychotherapies are available or feasible or the patient prefers
Olanzapine is not currently approved by the Food and Drug Administration for use in people with dementia
Dosage adjustments, if indicated, can be made according to efficacy and tolerability within dose ranges of oral olanzapine 5 to 12
loss of memory
Enlarged breasts, nipple discharge, not able to get or keep an erection (in males), or period (menstrual) changes (in females)
It works by changing the activity of certain natural substances in the brain
Olanzapine is also known as a second generation antipsychotic (SGA) or atypical antipsychotic
It is also known by the trade names Zalasta, Zyprexa and ZypAdhera
But on the other end of the spectrum, insomnia is another common side effect
delusional disorder, substance-induced psychotic disorder, paraphrenia, and psychotic disorders due to medical conditions
Olanzapine belongs to a group of medicines called antipsychotics
Old age, organicity, epilepsy, hypertension, bipolar disorders, and comorbid OCD are few known factors associated with Olanzapine-induced seizures
Clozapine was thought to be the cause of his obsessive–compulsive symptoms (OCS), so the dose was reduced to 300 mg/d over a period of 1 week
seizures
The FDA has approved this medication for schizophrenia if the patient is over the age of 13 and bipolar disorder, including mixed or manic episodes
5 or 5 mg daily
So far no single pathogenetic theory convincingly explained this fact suggesting heterogeneous subgroups
62% of reviewers reported a positive experience, while 19% reported a negative experience